Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Study of Interventional Therapy Sequential With the Fourth-generation CAR-T Cells (IL7 and CCL19 or / and IL12) Targeting Nectin4/FAP in the Treatment of Advanced Malignant Solid Tumors With Nectin4-positive

NCT03932565 is registered in ClinicalTrials.gov with The Sixth Affiliated Hospital of Wenzhou Medical University as lead sponsor.

NCT NCT03932565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03932565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Study of Interventional Therapy Sequential With the Fourth-generation CAR-T Cells (IL7 and CCL19 or / and IL12) Targeting Nectin4/FAP in the Treatment of Advanced Malignant Solid Tumors With Nectin4-positive
Lead sponsor
The Sixth Affiliated Hospital of Wenzhou Medical University
Phase
Phase 1
Overall status
Unknown status
Start date
February 13, 2019
Completion date
December 31, 2021
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nectin4-positive advanced malignant solid tumor